ATR and head and neck squamous cell carcinoma: The combination of targeting proteins involved in DNA damage repair (particularly PARP, DNA-Pk and ATR) and in cell-cycle checkpoint activation (particularly CHK1), have been demonstrated to enhance the radiosensitivity of HNSCC cells in vitro with some evidence also being generated in xenograft models in vivo.